CLNN
CLNN
NASDAQ · Biotechnology

Clene Inc

$3.92
-0.08 (-2.00%)
As of Nov 14, 2:36 AM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +381.1% upside
Low Target $15.04
Average Target $18.86
High Target $28.67
Current Price $3.92
Current
$3.92
Target
$18.86
$15.04 $18.86 avg $28.67
Scenario Analysis
Bear Case
$15.04
283.7%
Low target
Base Case
$18.86
+381.1%
Avg target
Bull Case
$28.67
+631.4%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$10.84
-63.8% from high
52-Week Low
$3.02
+30.0% from low
Target vs 52W High
$18.86
+74.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%